Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)

Abstract. The incidence of pancreatic cancer has been rising worldwide, and its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Association, the Chinese...

Full description

Bibliographic Details
Main Authors: Yinmo Yang, Xueli Bai, Dapeng Bian, Shouwang Cai, Rufu Chen, Feng Cao, Menghua Dai, Chihua Fang, Deliang Fu, Chunlin Ge, Xiaochao Guo, Chunyi Hao, Jihui Hao, Heguang Huang, Zhixiang Jian, Gang Jin, Fei Li, Haimin Li, Shengping Li, Weiqin Li, Yixiong Li, Hongzhen Li, Tingbo Liang, Xubao Liu, Wenhui Lou, Yi Miao, Yiping Mou, Chenghong Peng, Renyi Qin, Chenghao Shao, Bei Sun, Guang Tan, Xiaodong Tian, Huaizhi Wang, Lei Wang, Wei Wang, Weilin Wang, Junmin Wei, Heshui Wu, Wenming Wu, Zheng Wu, Jingyong Xu, Changqing Yan, Xiaoyu Yin, Xianjun Yu, Chunhui Yuan, Taiping Zhang, Jixin Zhang, Jun Zhou, Yupei Zhao, on behalf of the Chinese Pancreatic Surgery Association
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2021-06-01
Series:Journal of Pancreatology
Online Access:http://journals.lww.com/10.1097/JP9.0000000000000072
id doaj-f38efe30264744cca70be1d7add4e385
record_format Article
spelling doaj-f38efe30264744cca70be1d7add4e3852021-09-22T02:59:46ZengWolters Kluwer Health/LWWJournal of Pancreatology2096-56642577-35772021-06-0142496610.1097/JP9.0000000000000072202106000-00001Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)Yinmo YangXueli BaiDapeng BianShouwang CaiRufu ChenFeng CaoMenghua DaiChihua FangDeliang FuChunlin GeXiaochao GuoChunyi HaoJihui HaoHeguang HuangZhixiang JianGang JinFei LiHaimin LiShengping LiWeiqin LiYixiong LiHongzhen LiTingbo LiangXubao LiuWenhui LouYi MiaoYiping MouChenghong PengRenyi QinChenghao ShaoBei SunGuang TanXiaodong TianHuaizhi WangLei WangWei WangWeilin WangJunmin WeiHeshui WuWenming WuZheng WuJingyong XuChangqing YanXiaoyu YinXianjun YuChunhui YuanTaiping ZhangJixin ZhangJun ZhouYupei Zhaoon behalf of the Chinese Pancreatic Surgery AssociationAbstract. The incidence of pancreatic cancer has been rising worldwide, and its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Association, the Chinese Society of Surgery, Chinese Medical Association revised the Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China (2014) after reviewing evidence-based and problem-oriented literature published during 2015–2021, mainly focusing on highlight issues regarding diagnosis and surgical treatment of pancreatic cancer, conversion strategies for locally advanced pancreatic cancer, treatment of pancreatic cancer with oligo metastasis, adjuvant and neoadjuvant therapy, standardized processing of surgical specimens and evaluation of surgical margin status, systemic treatment for unresectable pancreatic cancer, genetic testing, as well as postoperative follow up of patients with pancreatic cancer. Forty recommendation items were finally proposed based on the above issues, and the quality of evidence and strength of recommendations were graded using the Grades of Recommendation, Assessment, Development, and Evaluation system. This guideline aims to standardize the clinical diagnosis and therapy, especially surgical treatment of pancreatic cancer in China, and further improve the prognosis of patients with pancreatic cancer.http://journals.lww.com/10.1097/JP9.0000000000000072
collection DOAJ
language English
format Article
sources DOAJ
author Yinmo Yang
Xueli Bai
Dapeng Bian
Shouwang Cai
Rufu Chen
Feng Cao
Menghua Dai
Chihua Fang
Deliang Fu
Chunlin Ge
Xiaochao Guo
Chunyi Hao
Jihui Hao
Heguang Huang
Zhixiang Jian
Gang Jin
Fei Li
Haimin Li
Shengping Li
Weiqin Li
Yixiong Li
Hongzhen Li
Tingbo Liang
Xubao Liu
Wenhui Lou
Yi Miao
Yiping Mou
Chenghong Peng
Renyi Qin
Chenghao Shao
Bei Sun
Guang Tan
Xiaodong Tian
Huaizhi Wang
Lei Wang
Wei Wang
Weilin Wang
Junmin Wei
Heshui Wu
Wenming Wu
Zheng Wu
Jingyong Xu
Changqing Yan
Xiaoyu Yin
Xianjun Yu
Chunhui Yuan
Taiping Zhang
Jixin Zhang
Jun Zhou
Yupei Zhao
on behalf of the Chinese Pancreatic Surgery Association
spellingShingle Yinmo Yang
Xueli Bai
Dapeng Bian
Shouwang Cai
Rufu Chen
Feng Cao
Menghua Dai
Chihua Fang
Deliang Fu
Chunlin Ge
Xiaochao Guo
Chunyi Hao
Jihui Hao
Heguang Huang
Zhixiang Jian
Gang Jin
Fei Li
Haimin Li
Shengping Li
Weiqin Li
Yixiong Li
Hongzhen Li
Tingbo Liang
Xubao Liu
Wenhui Lou
Yi Miao
Yiping Mou
Chenghong Peng
Renyi Qin
Chenghao Shao
Bei Sun
Guang Tan
Xiaodong Tian
Huaizhi Wang
Lei Wang
Wei Wang
Weilin Wang
Junmin Wei
Heshui Wu
Wenming Wu
Zheng Wu
Jingyong Xu
Changqing Yan
Xiaoyu Yin
Xianjun Yu
Chunhui Yuan
Taiping Zhang
Jixin Zhang
Jun Zhou
Yupei Zhao
on behalf of the Chinese Pancreatic Surgery Association
Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
Journal of Pancreatology
author_facet Yinmo Yang
Xueli Bai
Dapeng Bian
Shouwang Cai
Rufu Chen
Feng Cao
Menghua Dai
Chihua Fang
Deliang Fu
Chunlin Ge
Xiaochao Guo
Chunyi Hao
Jihui Hao
Heguang Huang
Zhixiang Jian
Gang Jin
Fei Li
Haimin Li
Shengping Li
Weiqin Li
Yixiong Li
Hongzhen Li
Tingbo Liang
Xubao Liu
Wenhui Lou
Yi Miao
Yiping Mou
Chenghong Peng
Renyi Qin
Chenghao Shao
Bei Sun
Guang Tan
Xiaodong Tian
Huaizhi Wang
Lei Wang
Wei Wang
Weilin Wang
Junmin Wei
Heshui Wu
Wenming Wu
Zheng Wu
Jingyong Xu
Changqing Yan
Xiaoyu Yin
Xianjun Yu
Chunhui Yuan
Taiping Zhang
Jixin Zhang
Jun Zhou
Yupei Zhao
on behalf of the Chinese Pancreatic Surgery Association
author_sort Yinmo Yang
title Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
title_short Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
title_full Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
title_fullStr Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
title_full_unstemmed Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)
title_sort guidelines for the diagnosis and treatment of pancreatic cancer in china (2021)
publisher Wolters Kluwer Health/LWW
series Journal of Pancreatology
issn 2096-5664
2577-3577
publishDate 2021-06-01
description Abstract. The incidence of pancreatic cancer has been rising worldwide, and its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Association, the Chinese Society of Surgery, Chinese Medical Association revised the Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China (2014) after reviewing evidence-based and problem-oriented literature published during 2015–2021, mainly focusing on highlight issues regarding diagnosis and surgical treatment of pancreatic cancer, conversion strategies for locally advanced pancreatic cancer, treatment of pancreatic cancer with oligo metastasis, adjuvant and neoadjuvant therapy, standardized processing of surgical specimens and evaluation of surgical margin status, systemic treatment for unresectable pancreatic cancer, genetic testing, as well as postoperative follow up of patients with pancreatic cancer. Forty recommendation items were finally proposed based on the above issues, and the quality of evidence and strength of recommendations were graded using the Grades of Recommendation, Assessment, Development, and Evaluation system. This guideline aims to standardize the clinical diagnosis and therapy, especially surgical treatment of pancreatic cancer in China, and further improve the prognosis of patients with pancreatic cancer.
url http://journals.lww.com/10.1097/JP9.0000000000000072
work_keys_str_mv AT yinmoyang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT xuelibai guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT dapengbian guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT shouwangcai guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT rufuchen guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT fengcao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT menghuadai guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT chihuafang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT deliangfu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT chunlinge guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT xiaochaoguo guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT chunyihao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT jihuihao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT heguanghuang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT zhixiangjian guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT gangjin guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT feili guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT haiminli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT shengpingli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT weiqinli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT yixiongli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT hongzhenli guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT tingboliang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT xubaoliu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT wenhuilou guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT yimiao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT yipingmou guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT chenghongpeng guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT renyiqin guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT chenghaoshao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT beisun guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT guangtan guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT xiaodongtian guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT huaizhiwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT leiwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT weiwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT weilinwang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT junminwei guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT heshuiwu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT wenmingwu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT zhengwu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT jingyongxu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT changqingyan guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT xiaoyuyin guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT xianjunyu guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT chunhuiyuan guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT taipingzhang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT jixinzhang guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT junzhou guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT yupeizhao guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
AT onbehalfofthechinesepancreaticsurgeryassociation guidelinesforthediagnosisandtreatmentofpancreaticcancerinchina2021
_version_ 1717371977160720384